Canberra Hospital is a major tertiary public hospital located in Garran, Canberra, Australian Capital Territory. It is the largest hospital in the region with 672 beds catering to a population of about 550,000.

There are 672 beds in Canberra Hospital.

During the past decade, Canberra Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Canberra Hospital" #1 sponsor was "Australasian Gastro-Intestinal Trials Group" with 3 trials, followed by "Australian and New Zealand Intensive Care Research Centre" with 3 trials sponsored, "Trans Tasman Radiation Oncology Group" with 3 trials sponsored, "The George Institute" with 2 trials sponsored and "University of Sydney" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Canberra Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 7 trials as a collaborator, "Academic and Community Cancer Research United" with 2 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator and "The George Institute" with 2 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Canberra Hospital" are "Atrial Fibrillation" (2 trials), "Gastro-Oesophageal Cancer" (2 trials), "Stroke" (2 trials), "Acute Heart Failure" (1 trials) and "Acute Renal Failure" (1 trials). Many other conditions were trialed in "Canberra Hospital" in a lesser frequency.

Most popular intervention types in "Canberra Hospital" are "Drug" (18 trials), "Procedure" (5 trials), "Radiation" (4 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Regorafenib" (3 trials), "ARB + DMX-200" (1 trials), "AV nodal ablation" (1 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Canberra Hospital" are 25 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Canberra Hospital". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Canberra Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Canberra Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".